Corrigendum to “Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs)” [Cancer Treatment Reviews 123 (2024) 102672]

IF 10.5 1区医学 Q1 ONCOLOGY Cancer treatment reviews Pub Date : 2024-04-01 Epub Date: 2024-03-16 DOI:10.1016/j.ctrv.2024.102714

Arianna Dri , Grazia Arpino , Giampaolo Bianchini , Giuseppe Curigliano , Romano Danesi , Michelino De Laurentiis , Lucia Del Mastro , Alessandra Fabi , Daniele Generali , Alessandra Gennari , Valentina Guarneri , Daniele Santini , Edda Simoncini , Claudio Zamagni , Fabio Puglisi

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

打破三阴性乳腺癌（TNBC）的障碍--释放抗体药物共轭物（ADC）的力量》[《癌症治疗评论》123 (2024) 102672]勘误表

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cancer treatment reviews 医学-肿瘤学

CiteScore

21.40

自引率

0.80%

发文量

109

审稿时长

13 days

期刊介绍： Cancer Treatment Reviews Journal Overview: International journal focused on developments in cancer treatment research Publishes state-of-the-art, authoritative reviews to keep clinicians and researchers informed Regular Sections in Each Issue: Comments on Controversy Tumor Reviews Anti-tumor Treatments New Drugs Complications of Treatment General and Supportive Care Laboratory/Clinic Interface Submission and Editorial System: Online submission and editorial system for Cancer Treatment Reviews

期刊最新文献

Editorial Board Integrating antibody-drug conjugates into the management of early breast cancer Proton therapy in breast cancer: bridging medical and radiation oncology Circulating tumor DNA in breast cancer: From technological foundation to clinical implementation Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer